Outset Medical, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
OM$4.23+3.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Operations
(in thousands, except per share amounts)
| Three Months Ended | ||
|---|---|---|
| March 31, | ||
| 2026 | 2025 | |
| Revenue: | ||
| Product revenue | $18,550 | $21,294 |
| Service and other revenue | 9,313 | 8,458 |
| Total revenue | 27,863 | 29,752 |
| Cost of revenue: | ||
| Cost of product revenue | 8,833 | 11,002 |
| Cost of service and other revenue | 6,935 | 7,684 |
| Total cost of revenue | 15,768 | 18,686 |
| Gross profit | 12,095 | 11,066 |
| Operating expenses: | ||
| Research and development | 5,618 | 5,515 |
| Sales and marketing | 13,279 | 13,652 |
| General and administrative | 10,117 | 8,298 |
| Total operating expenses | 29,014 | 27,465 |
| Loss from operations | (16,919) | (16,399) |
| Interest income and other income, net | 1,527 | 1,976 |
| Interest expense | (3,369) | (3,560) |
| Loss on extinguishment of term loan | — | (7,685) |
| Loss before provision for income taxes | (18,761) | (25,668) |
| Provision for income taxes | 217 | 115 |
| Net loss | $(18,978) | $(25,783) |
| Net loss per share, basic and diluted | $(1.03) | $(3.66) |
| Shares used in computing net loss per share, basic and diluted | 18,373 | 7,038 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.